Study Links Toxic Compounds in False Morel Mushrooms to ALS Cases in French Village
A recent study published in eNeurologicalSci has identified a potential link between the consumption of false morel mushrooms and a cluster of amyotrophic lateral sclerosis (ALS) cases in Montchavin, a small Alpine village in France. Over nearly three decades, 14 to 16 individuals in this village were diagnosed with ALS, a rare neurodegenerative disease. The study, led by Dr. Emmeline Lagrange at Grenoble Alpes University Hospital, found measurable levels of a toxic compound, gyromitrin, in the mushrooms consumed by the patients. This compound can transform into monomethylhydrazine, a toxin that interferes with vitamin B6, essential for nerve signaling. The findings suggest that repeated low-dose exposure to this toxin could lead to DNA damage and impair motor neurons over time.